title: Efficient transformation and regeneration of transgenic cassava using the neomycin phosphotransferase gene as aminoglycoside resistance marker gene.
abstract: Cassava is one of the most important crops in the tropics. Its industrial use for starch and biofuel production is also increasing its importance for agricultural production in tropical countries. In the last decade cassava biotechnology has emerged as a valuable alternative to the breeding constraints of this highly heterozygous crop for improved trait development of cassava germplasm. Cassava transformation remains difficult and time-consuming because of limitations in selecting transgenic tissues and regeneration of transgenic plantlets. We have recently reported an efficient and robust cassava transformation protocol using the hygromycin phosphotransferase II (hptII) gene as selection marker and the aminoglycoside hygromycin at optimal concentrations to maximize the regeneration of transgenic plantlets. In the present work, we expanded the transformation protocol to the use of the neomycin phosphotransferase II (nptII) gene as selection marker. Several aminoglycosides compatible with the use of nptII were tested and optimal concentrations for cassava transformation were determined. Given its efficiency equivalent to hptII as selection marker with the described protocol, the use of nptII opens new possibilities to engineer transgenic cassava lines with multiple T-DNA insertions and to produce transgenic cassava with a resistance marker gene that is already deregulated in several commercial transgenic crops.
authors.affiliation: Department of Biology, Plant Biotechnology, ETH Zurich, Zurich, Switzerland.
authors.forename: Michael
authors.initials: M
authors.lastname: Niklaus
authors.forename: Wilhelm
authors.initials: W
authors.lastname: Gruissem
authors.forename: Hervé
authors.initials: H
authors.lastname: Vanderschuren
mesh_terms: D000617:Aminoglycosides / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D004269:DNA, Bacterial / Q000235:genetics; D004351:Drug Resistance / Q000235:genetics; D019868:Kanamycin Kinase / Q000235:genetics / Q000378:metabolism; D002365:Manihot / Q000196:embryology / Q000235:genetics* / Q000502:physiology; D009355:Neomycin / Q000494:pharmacology; D030821:Plants, Genetically Modified / Q000196:embryology / Q000235:genetics* / Q000502:physiology; D012038:Regeneration / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D012639:Seeds / Q000235:genetics / Q000502:physiology; D046509:Tissue Culture Techniques; D014170:Transformation, Genetic
chemical_list: D000617:Aminoglycosides; D001426:Bacterial Proteins; D004269:DNA, Bacterial; C036483:T-DNA; D019868:Kanamycin Kinase; D009355:Neomycin